|
CCDC138 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6532109842492E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.340172748447E-12 |
| Normal-vs-Stage2 |
2.92643687060945E-12 |
| Normal-vs-Stage3 |
3.19089199507516E-12 |
| Normal-vs-Stage4 |
2.44249065417534E-14 |
| Stage1-vs-Stage2 |
2.009400E-01 |
| Stage1-vs-Stage3 |
6.255200E-01 |
| Stage1-vs-Stage4 |
7.142200E-03 |
| Stage2-vs-Stage3 |
1.548230E-01 |
| Stage2-vs-Stage4 |
3.867600E-01 |
| Stage3-vs-Stage4 |
1.625720E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.79714054538272E-12 |
| Normal-vs-AfricanAmerican |
5.56459999967451E-07 |
| Normal-vs-Asian |
1.43919987038998E-10 |
| Caucasian-vs-AfricanAmerican |
7.790000E-01 |
| Caucasian-vs-Asian |
7.838400E-01 |
| AfricanAmerican-vs-Asian |
7.065600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.62556643093603E-12 |
| Normal-vs-Female |
4.81004125418849E-12 |
| Male-vs-Female |
2.873000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.57467397296796E-12 |
| Normal-vs-Age(41-60Yrs) |
2.58815191500616E-12 |
| Normal-vs-Age(61-80Yrs) |
1.10129683150717E-11 |
| Normal-vs-Age(81-100Yrs) |
1.675050E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.956400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.645000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.611600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.720200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.326800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.748000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.268800E-01 |
| Classical-VS-Follicular |
7.192200E-01 |
| Classical-VS-Other |
6.916400E-01 |
| Classical-VS-Normal |
1.86090032272546E-11 |
| Tall-VS-Follicular |
7.241200E-01 |
| Tall-VS-Other |
7.202800E-01 |
| Tall-VS-Normal |
1.16640000002999E-06 |
| Follicular-VS-Other |
8.172800E-01 |
| Follicular-VS-Normal |
3.24670290652307E-11 |
| Other-VS-Normal |
1.73538999999057E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.35484981409218E-12 |
| Normal-vs-N1 |
2.87547763377916E-14 |
| N0-vs-N1 |
4.952300E-02 |
|
|
